Novel treatment (new drug/intervention; established drug/procedure in new situation)
Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia
1 Hopital Nord, Internal Medicine, Chemin des Bourrely, Marseille, 13915, France
2 Etablissement Français du Sang, Boulevard Baille, Marseille, 13385, France
3 Hopital Nord, Haematology, Chemin des Bourrely, Marseille, 13915, France
4 Hopital Conception, Rheumatology, Boulevard Baille, Marseille, 13385, France
Correspondence to:
Brigitte Granel, bgranel{at}ap-hm.fr
Mixed warm and cold autoimmune anaemia is a rare haemolytic anaemia that is commonly associated with lymphoproliferative disorders and autoimmune diseases. Although steroid therapy is the first-line treatment, rituximab represents a good alternative. The present study reports on a successful treatment with rituximab in a young woman suffering from a mixed warm and cold autoimmune haemolytic anaemia associated with a mixed connective tissue disease.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full text of all Editor's Choice articles and summaries of every article are free without registration
The full text of Images in ... articles are free to registered users
Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource
Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog
